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Abstract
Background: Resistin is an adipocyte hormone that regulates glucose metabolism. Elevated levels of resistin may
cause insulin resistance. This may link obesity, and increased fat mass to type II diabetes and insulin resistance. We
hypothesized that treatment with tomato and broccoli extracts regulates glucose homeostasis via modulation of
resistin levels in high fat diet-induced obesity rats (HFD).
Methods: Forty-eight male albino rats were divided into 8 groups as follows: control, HFD, stop fat diet (SD),
Tomato 200 mg/kg (T200), Tomato 400 mg/kg (T400), Broccoli 200 mg/kg (B200), Broccoli 400 mg/kg (B400), and
Chromax (CX). Treatment continued for 1 month. Serum levels of resistin, leptin, adiponectin, glucose and insulin
were measured using ELISA and spectrophotometry.
Results: Serum levels of resistin were significantly reduced in the T 200, T 400, B 200, B 400 and CX groups to: 4.
13 ± 0.22 ng/ml, 1.51 ± 0.04 ng/ml, 4.13 ± 0.22 ng/ml, 2.32 ± 0.15 ng/ml and 1.37 ± 0.03 ng/ml, respectively,
compared to HFD group and SD group (P value < 0.0001). Non-significant differences were found between T 400,
B 400 and CX groups. Serum levels of leptin were significantly reduced in the T 400 (22.7 ± 0.84 pg/ml) group
compared to the B 400 (41 ± 2.45 Pg/ml) and CX groups (45.7 ± 2.91 Pg/ml), P value < 0.001. Serum levels of
adiponectin were significantly increased in the T 400 group (131 ± 3.84 pg/ml) compared to the CX group (112 ±
4.77 pg/ml), P value < 0.01.
Conclusions: Our results demonstrate that tomato and broccoli extract treatment regulates glucose homeostasis
via reduction of serum resistin and may be a useful non-pharmacological therapy for obesity.
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Background
Obesity is an escalating global and societal problem.
Associated environmental factors such as poor dietary
habits, sedentary lifestyle, socioeconomic influences; and
genetic disorders that affect hormone secretion and
metabolism result in weight gain [1]. Western-style
diets, low in dietary fiber and high in saturated fatty
acids, are implicated in increased risk of diabetes and
obesity [2]
Adipose tissues are now considered to actively regulate
the pathways responsible for energy balance. A complex
network of hormonal and neuronal signals controls the
activity of these pathways. Adipocytes secrete chemical
substances called adipocytokines like leptin, adiponectin,
resistin, tumor necrosis factor (TNF)-α, interleukin-6,
and angiotensinogen [3].
Resistin was identified as an adipocyte hormone that
participates in the regulation of glucose metabolism,
increasing blood glucose levels and hepatic glucose
production. Elevated levels of resistin are postulated to
cause insulin resistance. This may link obesity, and
increased fat mass to type 2 diabetes and insulin
resistance [4].
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There is a continuous effort among researchers and
dieticians to identify food items or dietary components
that may prevent or treat obesity and its complications.
It was reported that tomato (Solanum lycopersicum L.,
Family Solanaceae), might serve as a functional food that
has beneficial effects on health other than nutrition [5].
These effects include but are not limited to anti-platelet,
anti-oxidant and anti-cancer effects [6, 7]. Tomato was
also found to inhibit the cancer cell proliferation in-
duced by some estrogens [8, 9]. Tomato extract was
effective in protecting against liver inflammation in-
duced by a high fat diet (HFD)-by decreasing both the
number of inflammatory foci and the expression of
multiple pro-inflammatory cytokines [10].
Broccoli (Brassica oleracea L. Italica, Family Brassica-
ceae) is another candidate of functional foods. Broccoli
might be beneficial in reducing the risk for the develop-
ment of certain forms of cancer as well as its antioxidant
effect [11–13]. It was also recently found that broccoli
extract was found to increase glucose uptake and induce
lipogenesis in cell culture [14]. Also, broccoli fiber and
high dietary corn oil resulted in lower serum cholesterol
and triglycerides, which may have beneficial effects on
lipid metabolism [15].
In this study we investigated the potential role of
aqueous extracts of tomato and broccoli grown in Egypt
in regulating blood glucose level in HFD-induced obesity
in rats, as well as the possible role of resistin in mainte-
nance of glucose homeostasis. We also studied the nutri-
tional values of these foods to assess their potential use
as functional foods.
Methods
Plant collection and preparation of extracts
Plant material
Ten kilograms of the fresh stalks and flower heads of
broccoli (cultivar Snowball) were collected from the El
Orman botanical garden, Giza, Egypt. Nine kilograms of
the fresh fruits of Tomato (cultivar Peto 86) were collected
from the National Research Center Agricultural Station,
Nubaria, Behera Governorate, Egypt. The taxonomical
identity was kindly verified by Dr. Mohamed El Gebaly,
National Research Center, Giza, Egypt. The material was
collected during 2015. The fresh plant material was used
for the phytochemical investigations. A voucher specimen
was deposited in the herbarium of The Faculty of
Pharmacy, Modern Science and Arts University (MSA).
Extract preparations
The plant materials were separately grinded then
macerated in distilled water for 24 h. The aqueous ex-
tracts were concentrated under reduced pressure and
kept in tightly closed amber glass containers for bio-
chemical analysis.
Two doses of 200 mg/kg and 400 mg/kg were selected
and used in this study for both tomato and broccoli
extracts [9]. The two doses were prepared by dissolving
0.5 or 1 mg of this extract into 10 ml distilled water [16].
Reference material and solvents
Authentic vitamins (A, B1, B2, B3, B6, B12, C and E)
were kindly supplied by the Agricultural Research
Center, Food Technology Research Institute, Giza, Egypt.
All chemical reagents and solvents were analytical grade.
Phytochemical Investigations
Proximate analysis
Proximate analysis of tomato and broccoli fresh samples
included the determination of their nutritive value,
moisture content, total ash, total carbohydrates, total
lipids and total proteins. The nutritive values were deter-
mined by multiplying the values obtained for protein, fat
and carbohydrate by 4, 9 and 4, respectively and adding
up the values [17]. The moisture contents, total ash
content, total protein and lipid extraction were deter-
mined according to A.O.A.C guidelines [18–20]. Total
carbohydrates were determined according to (Dubois et
al. 1956 [21].
Analysis of the mineral content
The mineral content was determined according to
A.O.A.C guidelines [19]. Samples were separately digested
in an Advanced Microwave Digestion System ETHOS 1 by
wet digestion with concentrated sulfuric acid in the pres-
ence of digestion catalysts (a mixture of copper sulfate and
anhydrous sodium sulfate, 1:10), then the resulted solutions
were measured using an Atomic Absorption Spectrometer
(Inductively Coupled Plasma ICP-AES Spectrometer, iCAP
6000 series, Thermo Scientific).
Determination of vitamins by HPLC
A Hewlett-Packard Series 1,100 liquid chromatography
system (Waldbronn, Germany) equipped with a loop
(20 μl) diode array detector and a lichrosorb RP 15
column (4.0 mm i.d.x 250 mm; particle size 5 mm)
(Merck, Darmstadt) was used for vitamin content deter-
mination. Elution was performed at a flow rate of
1.0 ml/min with a mobile phase of water/acetic acid
(98: 2 v/v, solvent A) and methanol/acetonitrile (50: 50, v/
v, solvent B), starting with 5 % B and increasing B to levels
of 30 % at 25 min, 40 % at 35 min, 52 % at 40 min, 70 % at
50 min, 100 % at 55 min, and kept at this stage for 5 min.
A re-equilibration time of 15 min was then required.
Quantitation was achieved at 280 nm by an internal stan-
dard method [22]. Vitamins A and E contents were deter-
mined according to the method described by Beyer &
Jensen 1989 [23], while vitamin C content was determined
according to the method described in Romeu-Nadal et al.,
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2006 [24], and vitamin B complex content was determined
according to the method described in Batifoulier, et al.,
2005 [25].
Animals
Forty-eight male albino rats were used, weighting 130 ±
10 g at the start of the experiments. Prior to the studies,
the animals were randomly and assigned to treatment
groups. Four rats were housed per cage (size 26 × 41 cm)
and placed in the experimental room for acclimatization
24 h before the test. The animals were fed with standard
laboratory diet and with tap water ad libitum, and kept
in an air-conditioned animal room at 23 ± 1 °C with a
12 h light/dark cycle. Animal care and handling was
performed in conformance with approved protocols of
Cairo University and Egyptian Community guidelines for
animal care.
Experimental induction of obesity by HFD
Control rats received a normal pellet diet (NPD) for
three months the remaining rats received HFD to esta-
blish diet-induced obesity. It provides 58 % fat, 25 %
protein and 17 % carbohydrate, as a percentage of total
kcal. The composition and preparation of HFD was
described by Srinivasan et al., 2004 [26] as the following
components (g/kg): powdered NPD, 365 (Egyptian
market); lard, 310 (Egyptian market); casein, 250 (Difco,
Becton Dickinson, France); cholesterol, 10 (Oxford Lab,
Mumbai, India); vitamin and mineral mix, 60 (Sigma–
Aldrich, MO, USA; 8ADWIC Co., Cairo, Egypt); DL-
methionine, 3.0 (Sigma–Aldrich, MO, USA; 8 ADWIC
Co., Cairo, Egypt); Yeast powder, 1.0 (Egyptian market),
sodium chloride, 1.0 (Egyptian market).
Experimental design
Rats were randomly allocated into eight groups of six
animals each:
Group 1: normal control group fed NPD.
Group 2 (HFD): rats received HFD for 3 month.
Group 3 (SD): rats received HFD for 2 month and
returned to NPD for 1 month.
Group 4 (T 200): rats received HFD for 2 month, then
returned to NPD and treated with tomato extract
200 mg/kg/day, p.o. for 1 month.
Group 5 (T 400): rats received HFD for 2 month, then
returned to NPD and treated with tomato extract
400 mg/kg/day, p.o. for 1 month.
Group 6 (B 200): rats received HFD for 2 month, then
returned to NPD and treated with broccoli extract
200 mg/kg/day, p.o. for 1 month.
Group 7 (B 400): rats received HFD for 2 month, then
returned to NPD and treated with broccoli extract
400 mg/kg/day, p.o. for 1 month.
Group 8 (CX): rats received HFD for 2 month, then
returned to NPD and treated with Chromax 400 μg/kg/
day, p.o. for 1 month.
Drugs
Chromax (Eva Pharma, Egypt) was dissolved in distilled
water and administered orally.
Toxicity study
The toxicity of aqueous extracts of tomato and broccoli
were tested using four doses (200, 400, 1000 and
2000 mg/kg) (six rats for each dose). Six control rats were
kept under the same conditions without any treatments.
The animals were observed continuously during the first
hour, and then every hour for 6 h, then after 12 and 24 h,
and finally after every 24 h, up to 3 weeks, for mortal-
ity or any physical signs of toxicity such as writhing,
gasping, salivation, diarrhea, cyanosis, pupil size, any
nervous manifestations.
Blood samples and biochemical analysis
At the end of the study, rats were fasted overnight,
anesthetized with thiopental sodium (50 mg/kg) [27],
and blood samples were collected from retinal vein
(5 ml per rat). Blood samples were centrifuged at
3000 rpm for 15–30 min after collection and stored at
−80 °C until analyzed. Serum glucose level was estimated
enzymatically using TECHNICAL BULLETIN Sigma
Aldrich (USA), and triglyceride levels (TGs) were
estimated using enzymatic assay kit from Xpress Bio Life
Science Products. Total cholesterol (TC), low-density
lipoprotein cholesterol (LDL-C) and high-density lipo-
protein cholesterol (HDL-C) were measured colorimetri-
cally using assay kits from Biochain (Hayward, USA)
according to the manufactured instructions.
ELISA
Serum insulin, resistin, leptin, and adiponectin were
determined using the corresponding rat enzyme immuno-
assay kits (insulin: SPI bio, Downers Grove, France,
resistin: Biovendor research and diagnostic products,
leptin: RayBiotech, Inc., Norcross GA, USA, adiponectin:
Chemicon international, USA, and AST: Shanghai Sunred
Biological Technology Co., China) using an ELISA micro-
plate reader Sunrise, TECAN, Austria.
Calculation of insulin sensitivity, resistance, adipose tissue
index
Insulin resistance was determined using the homeostasis
model assessment index for insulin resistance (HOMA-IR)
using the following formula: HOMA-IR index = [fasting
glucose (mg/dl) * fasting insulin (μU/ml)]/405). To assess
insulin sensitivity, the revised quantitative insulin sensitivity
check index (R-QUICKI) = 1/[log fasting insulin (μU/ml) +
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log fasting glucose (mg/dl)] was used [28, 29]. Additionally,
the adipose tissue index (API = retroperitoneal adipose
tissue X100) was calculated.
Statistical analyses
All data were expressed as mean ± standard error of
mean (SEM) and analyzed using prism program version
6. For all parameters, comparisons among groups were
carried out using one-way analysis of variance (ANOVA)
followed by Bonferroni’s multiple comparisons test. All




The toxicity study revealed the non-toxic nature of
aqueous extracts of tomato and broccoli at doses up to 2
gm/kg. No deaths were reported, and the rats did not
show any drug-induced physical signs of toxicity during
the whole experiment period.
Effect of tomato and broccoli extract on blood glucose,
insulin and insulin resistance markers
The results of the experiments are summarized in
Table 1. Mean serum levels of insulin and glucose were
significantly increased in the HFD and SD groups com-
pared to the control group (P value < 0.0001). On the
other hand, the mean serum levels of insulin and glucose
were significantly reduced in the T 200, T 400, B 200, B
400 and CX groups when compared to the HFD and SD
groups (P value < 0.0001). The mean serum level of
insulin was significantly reduced in the T 400 group com-
pared to the B 400 and CX groups (P value < 0.001) while
glucose serum level was significantly reduced in the T 400
group compared to the B 400 group (P value < 0.01). No
significant difference of glucose serum level was found be-
tween the T 400 and CX groups.
The calculated HOMA-IR was significantly increased
while R-QUICKI was significantly reduced in the HFD
and SD groups compared to the control group (P value <
0.0001). HOMA-IR values were significantly reduced
while R-QUICKI values were significantly increased in the
T 200, T 400, B 200, B 400 and CX groups when com-
pared to the HFD and SD groups (P value < 0.0001).
HOMA-IR values were also significantly reduced while R-
QUICKI was also significantly increased in the T 400
group compared to the B 400 and CX groups (P value
was < 0.05), (Table 1).
Effect of tomato and broccoli extract on body weight and
adipose tissue index
The % weight increase was significantly larger in the
HFD and SD groups compared to the control group
(P value < 0.0001). However, the % weight increase
was significantly reduced in the SD, T 200, T 400,
B200, B 400 and CX groups compared to the HFD
group (P value < 0.001). The API was significantly in-
creased in the HFD and SD groups compared to the
control group (P value was < 0.0001). In contrast, the
API was significantly reduced in the T 200, T 400,
B200, B 400 and CX groups compared to the HFD
group (P value < 0.001). The difference in the API be-
tween the T 400 and B 400 groups compared to the
control group was not significant (Table 2).
Effect of tomato and broccoli extract on serum lipid
profile
Mean serum level of total cholesterol, triglycerides and
LDL-cholesterol were significantly increased in the HFD
group compared to the control group (P value < 0.0001).
Table 1 Effect of tomato and broccoli extract on serum insulin, glucose, on calculated HOMA- IR and R-QUICKI in HFD induced
obesity in rats
Groups Serum insulin (uIU/ml) Serum glucose (mg/dl) HOMA-IR R-QUICKI
Control 2.52 ± 0.28 67.8 ± 3.23 0.43 ± 0.06 0.455 ± 0.01
HFD 44.1 ± 2.14* 169 ± 1.38* 18.5 ± 0.96* 0.25 ± 0.004*
SD 30.9 ± 1.28*,** 156 ± 1.86*,** 11.9 ± 0.41*,** 0.27 ± 0.004*,**
T 200 12.1 ± 0.75*,**,*** 138 ± 3.82*,**,*** 4.15 ± 0.34*,**,*** 0.31 ± 0.008*,**,***
T 400 6.72 ± 0.36*,**,*** 99.3 ± 4.0*,**,*** 1.66 ± 0.15*,**,*** 0.35 ± 0.01*,**,***
B 200 19 ± 0.71*,**,*** 136 ± 3.0*,**,*** 6.39 ± 0.22*,**,*** 0.29 ± 0.004*,**,***
B 400 9.38 ± 0.47*,**,***,**** 115 ± 2.96*,**,***,**** 2.67 ± 0.18*,**,***,**** 0.33 ± 0.008*,**,***,****
CX 9.48 ± 0.53*,**,***,**** 108 ± 2.79*,**,*** 2.54 ± 0.2*,**,***,**** 0.33 ± 0.01*,**,***,****
Tomato and broccoli extracts treatment at different doses significantly reduced serum levels of insulin and glucose in HFD rats. These extracts also
significantly reduced HOMA-IR increased R- QUICKI. C = control; HFD = high fat diet; SD = stop diet; T 200 = tomato extract 200 mg/kg; T 400 = tomato
400 mg/kg; B 200 = broccoli 200 mg/kg; B 400 = broccoli 400 mg/kg; CX = Chromax. HOMA-IR = Homeostasis model assessment index for insulin resistance;
R-QUICKI = revised quantitative insulin sensitivity check index. Results were expressed as mean ± SEM and analyzed using one-way ANOVA followed by
Bonferroni’s post hoc test. *Significant from control at P < 0.0001, **Significant from HFD at P < 0.0001, ***Significant from SD at P < 0.0001, ****Significant
from T 400 at P < 0.005. Results were expressed as mean ± SEM and analyzed using one-way ANOVA followed by Bonferroni’s post hoc test
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The serum level of total cholesterol, triglycerides and
LDL-cholesterol were significantly reduced in T 200, T
400, B 200, B 400 and CX groups compared to HFD
group (P value < 0.0001). Although total cholesterol,
LDL, and triglycerides were significantly reduced in T
400 group compared to B 400 with no significant diffe-
rence between T 400 group and CX group, LDL-
cholesterol was significantly reduced in T 400 group
compared to B 400 and CX groups (P value < 0.001).
HDL-cholesterol levels were significantly reduced in
the HFD group compared to the control group (P value
was < 0.0001). The mean serum levels of HDL-
cholesterol were significantly increased in the T 200, T
400, B 200, B 400 and CX groups compared to the HFD
group (P value < 0.0001). No significant difference was
found between the T 400, B 400 and CX groups. There
was also no significant difference between the control
and SD groups in lipid profile (Table 3).
Effect of tomato and broccoli extract on serum resistin,
leptin and adiponectin
The mean serum level of resistin and leptin were signifi-
cantly increased in the HFD and SD groups compared to
the control group (P < 0.0001). Serum levels of resistin
and leptin were significantly reduced in the T 200, T
400, B 200, B 400 and CX groups compared to the HFD
and SD groups (P < 0.0001). Also, serum levels of resistin
and leptin were significantly reduced in the T 400 group
compared to the B 400 and CX groups (P < 0.001).
Adiponectin levels were significantly decreased in the
HFD and SD groups compared to the control group
(P < 0.0001). The mean serum level of adiponectin
was significantly increased in the T 200, T 400, B
200, B 400 and CX groups compared to the HFD and
SD groups (P < 0.0001). Serum adiponectin levels were
significantly increased in the T 400 group compared to the
CX group (P value < 0.001). No significant difference in
Table 2 Effect of tomato and broccoli extract on body weight and adipose tissue index in HFD induced obesity in rats
Groups Initial weight (gm) Final weight (gm) % Δ weight (gm) Adipose tissue index
Control 127 ± 1.59 166 ± 5.4 30.3 ± 2.89 0.82 ± 0.07
HFD 126 ± 1.49 259 ± 6.73 106 ± 5.13* 2.6 ± 0.21*
SD 126 ± 1.31 218 ± 5.36 72.8 ± 4.79*,** 2.21 ± 0.13*,**
T 200 128 ± 1.03 199 ± 7.39 56.1 ± 6.11*,**,*** 1.1 ± 0.04*,**,***
T 400 126 ± 1.59 190 ± 4.54 51.6 ± 4.11*,**,*** 0.81 ± 0.08**,***
B 200 133 ± 1.06 214 ± 5.68 60.4 ± 4.81*,** 1.47 ± 0.18*,**,***
B 400 132 ± 1.53 211 ± 9.12 59.1 ± 6.45*,** 1.03 ± 0.1**,***
CX 136 ± 1.28 221 ± 4.49 60.2 ± 3.19*,**,*** 1.58 ± 0.27*,**
Tomato and broccoli extracts treatment at different doses significantly reduced body weight and adipose tissue index in HFD rats. C = control; HFD = high fat diet;
SD = stop diet; T 200 = tomato extract 200 mg/kg; T 400 = tomato 400 mg/kg; B 200 = broccoli 200 mg/kg; B 400 = broccoli 400 mg/kg; CX = Chromax. Results were
expressed as mean ± SEM and analyzed using one-way ANOVA followed by Bonferroni’s post hoc test. * = Significant from control at P < 0.0001, **= Significant
from HFD at P < 0.0001, *** = Significant from SD at P < 0.05. Results were expressed as mean ± SEM and analyzed using one-way ANOVA followed by Bonferroni’s
post hoc test
Table 3 Effect of tomato and broccoli extract on lipid profile in HFD induced obesity in rats
Groups TC (mg/dl) TAG (mg/dl) LDL-C (mg/dl) HDL-C (mg/dl)
Control 53.7 ± 1.76 40 ± 1.06 19.3 ± 0.55 33.5 ± 0.76
HFD 147 ± 3.66* 145 ± 3.68* 102 ± 2.25* 14.5 ± 0.22*
SD 55.5 ± 1.95** 40.7 ± 1.02** 19.7 ± 0.71** 34.5 ± 0.76**
T 200 85.5 ± 1.57*,**,*** 79.5 ± 4.19*,**,*** 48.3 ± 1.15*,**,*** 23.7 ± 0.21*,**,***
T 400 62.3 ± 1.15*,**,*** 51 ± 0.85*,**,*** 27 ± 0.57*,**,*** 24.5 ± 0.22*,**,***
B 200 121 ± 2.62*,**,*** 127 ± 1.82*,**,*** 73.5 ± 3.14*,**,*** 18 ± 0.36*,**,***
B 400 84.2 ± 2.5*,**,***,**** 73.7 ± 1.8*,**,***,**** 48 ± 1.06*,**,***,**** 23.3 ± 0.61*,**,***
CX 63 ± 1.97*,**,*** 50 ± 1.88*,**,*** 31.2 ± 0.6*,**,***,**** 25.5 ± 0.22*,**,***
Tomato and broccoli extracts treatment at different doses significantly reduced lipid profile parameters in HFD rats. C = control; HFD = high fat diet; SD = stop diet;
T 200 = tomato extract 200 mg/kg; T 400 = tomato 400 mg/kg; B 200 = broccoli 200 mg/kg; B 400 = broccoli 400 mg/kg; CX = Chromax. TC = total cholesterol; TAG=
triglycerides; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density lipoprotein cholesterol. Results were expressed as mean± SEM and analyzed using one-way
ANOVA followed by Bonferroni’s post hoc test. * =Significant from control at P < 0.0001, **Significant from HFD at P < 0.0001, *** =Significant from SD at
P < 0.05, **** = Significant from T 400 at P < 0.005. Results were expressed as mean ± SEM and analyzed using one-way ANOVA followed by Bonferroni’s
post hoc test
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serum adiponectin levels was found between the control
and the T 400, B 400, and CX groups (Table 4 and Figs. 1,
2, and 3) Additional file 1.
Nutritional value of tomato and broccoli
Table 5 shows the proximate analysis, vitamin and
mineral contents of the fresh samples of tomato (S.
lycopersicum L.) and broccoli (B. oleracea L. Italica)
grown in Egypt that were used to make the extracts
used in this study.
Discussion
Obesity is becoming a global threat to human health. A
sedentary life style and change of diet are implicated in
the development of obesity [30]. Diabesity is a term that
expresses the association between obesity and type II
diabetes [31]. A high fat diet in rats has been shown to
induce metabolic syndrome similar to type II diabetes
and insulin resistance [3]. Since there is a great effort
among researchers to identify dietary components that
prevent or treat obesity complications, we investigated
the possible role of tomato and broccoli extract on
glucose homeostasis in HFD-induced obesity in rats.
This study reports for the first time that both broccoli
and tomato extracts improved glucose homeostasis in
HFD-induced obesity rats, possibly through the reduc-
tion of resistin in addition to their high nutritional value.
Tomato and broccoli extracts significantly reduced
serum level of glucose after one month of treatment in
HFD-induced obesity rats. Tomato and broccoli treat-
ment also improved the lipid profile, the API, as well as
adiponectin and leptin levels in HFD-induced obesity
rats of this study. Tomato extract at a concentration of
400 mg/kg was more effective in reducing glucose and
leptin and increasing adiponectin compared with broc-
coli and Chromax®, the commercially used chromium
supplement. This hypoglycemic hypolipidemic effect can
be attributed to improvement of whole body insulin
resistance [32].
To explain the mechanism by which these extracts
may work, we measured serum resistin in our rat model
of diabesity. Our results shows that treatment with
tomato and broccoli extracts significantly reduced serum
level of resistin compared to HFD group and SD group
(P value < 0.0001). Both tomato and broccoli extracts
had similar effects on serum resistin levels as Chromax®,
as there was a non-significant difference was found be-
tween the T 400, B 400 and CX groups (Table and Fig. 1).
These results could in part explain the hypoglycemic
effect of tomato and broccoli extracts observed in our
study. Resistin is an adipocyte hormone that participates
in the regulation of glucose metabolism, increasing the
blood glucose levels and hepatic glucose production.
Elevated levels of resistin are postulated to cause insulin
resistance [4]. Our results indeed support the role of
resistin in the maintenance of glucose homeostasis via a
resistin-mediated mechanism.
Our results are in agreement with many researchers
who have found beneficial effects of tomato in obesity
and the related metabolic syndrome. Ghavipour et al.,
[33] found that tomato juice administered to overweight
and obese women reduced the production of inflamma-
tory cytokines. Also Ghorbani et al. [34], observed anti-
oxidant effect for tomato juice in overweight and obese
women. To our knowledge this is the first report of the
effect of tomato extract on serum resistin level [4].
The observed effect of tomato extract in our study
could be attributed to the antioxidant effect of lycopene
(the most effective anti-oxidant of the carotenoids in
tomatoes). Kim et al., 2015 [35] found that tomato
extract potentially suppresses inflammation by inhibiting
the production of NO or pro-inflammatory cytokines
during the interaction between adipocytes and macro-
phages in cell culture. Since obesity is a chronic
Table 4 Effect of tomato and broccoli extract on serum resistin, leptin and adiponectin in HFD induced obesity in rats
Groups Resistin (ng/ml) Leptin (Pg/ml) Adiponectin (Pg/ml)
Control 0.93 ± 0.05 16.3 ± 0.57 120 ± 3.81
HFD 11.2 ± 0.48* 147 ± 3.70* 27.8 ± 0.94*
SD 8.05 ± 0.29*,** 118 ± 4.20*,** 40.2 ± 2.36*,**
T 200 4.13 ± 0.22*,**,*** 44.8 ± 2.13*,**,*** 95.5 ± 3.84*,**,***
T 400 1.51 ± 0.04*,**,*** 22.7 ± 0.84*,**,*** 131 ± 3.84*,**
B 200 5.91 ± 0.29*,**,*** 80.3 ± 3.14*,**,*** 78.5 ± 2.42*,**,***
B 400 2.32 ± 0.15*,**,***,**** 41 ± 2.45*,**,***,**** 122 ± 3.61*,**
CX 1.37 ± 0.03*,**,***,**** 45.7 ± 2.91*,**,***,**** 112 ± 4.77**,***,****
Tomato and broccoli extracts treatment at different doses significantly reduced serum resistin and leptin while increased adiponectin levels in HFD rats. C = control; HFD =
high fat diet; SD = stop diet; T 200 = tomato extract 200 mg/kg; T 400 = tomato 400 mg/kg; B 200 = broccoli 200 mg/kg; B 400 = broccoli 400 mg/kg; CX = Chromax
*= Significant from control at P < 0.0001, **Significant from HFD at P < 0.0001, ***Significant from SD at P < 0.05, ****Significant from T 400 at P < 0.001. Results
were expressed as mean ± SEM and analyzed using one-way ANOVA followed by Bonferroni’s post hoc test
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inflammatory condition and the inflammation is consid-
ered a source of oxidative stress, so lycopene can be use-
ful in this condition [34].
Broccoli extract appears to have similar beneficial
effects on glucose homeostasis as tomato extract.
Although tomato extract had more significant effect
in correcting glucose and insulin level (Table 1) at
the dose of 400 mg/kg, both had almost the same
effect on serum resistin level (Table 4 and Fig. 3).
Broccoli may exert its beneficial effect on glucose
homeostasis via its well-documented anti-oxidant ef-
fect [11, 36–39]. Also, Christensen et al., 2014 [14],
found that broccoli extract enhances glucose uptake
in porcine cell culture and stimulated the differenti-
ation of adipocytes in C. Elegans. These findings may
explain in part the beneficial effect of broccoli
extracts observed in our study.
The beneficial effects of both tomato and broccoli
extract on glucose and lipid homeostasis found here
could be also explained by the fact that both extract
are rich in chromium ([40] http://www.eufic.org/).
Chromium is a trace element that was found to have bene-
ficial effects on human health. Several studies have found







































Fig. 1 Serum level of resistin (ng/ml) in the experimental groups.
Tomato and broccoli extracts reduced serum level of resistin in
the HFD rats at the end of 1 month treatment; C = control; HFD =
high fat diet; SD = stop diet; T 200 = tomato extract 200 mg/kg; T 400 =
tomato 400 mg/kg; B 200 = broccoli 200 mg/kg; B 400 = broccoli
400 mg/kg; CX = Chromax. Results were expressed as mean ± SEM. and
analyzed using one-way ANOVA followed by Bonferroni’s post hoc test.
* = Significant from control at P< 0.0001, # = Significant from HFD at
P< 0.0001, $ = Significant from SD at P< 0.000, @ = Significant
from T 400 at P< 0.001






































Fig. 2 Serum level of leptin (pg/ml) in the experimental groups. Tomato
and broccoli extracts reduced serum level of leptin in the HFD rats at the
end of 1 month treatment; C = control; HFD = high fat diet; SD = stop
diet; T 200 = tomato extract 200 mg/kg; T 400 = tomato 400 mg/kg; B
200 = broccoli 200 mg/kg; B 400 = broccoli 400 mg/kg; CX = Chromax.
Results were expressed as mean± SEM and analyzed using one-way
ANOVA followed by Bonferroni’s post hoc test. * = Significant from
control at P< 0.0001, # = Significant from HFD at P< 0.0001, $ =
Significant from SD at P< 0.0001, @ == Significant from T 400 at P< 0.001
Table 5 Proximate analysis, vitamins contents and minerals
contents of the fresh samples of tomato (S. lycopersicum L.)
and broccoli (B. oleracea L. Italica)
Item Tomato Broccoli
Proximate analysis Nutritive Value 24.32 Kcal 41.76 Kcal
Percentage/Fresh weight
Moisture content 93.7 % 88.6 %
Total ash 0.46 % 0.87 %
Total carbohydrates 4.2 % 6.9 %
Total lipids 0.44 % 0.32 %
Total proteins 0.89 % 2.82 %
Vitamins Amount in 100 gm
fresh weight
Vitamin A (IU) 837 624
Vitamin E (mg) 0.539 0.36
Vitamin C (mg) 24.68 90.02
Vitamin B1 (mg) 0.057 0.121
Vitamin B2 (mg) 0.036 0.175
Vitamin B3 (mg) 0.54 0.69
Vitamin B6 (mg) 0.007 0.28
Vitamin B12 (mg) NDa NDa
Minerals Potassium (mg) 247.84 317.48
Calcium (mg) 15.98 48.07
Sodium (mg) 73.6 33.96
Chromium (mg) 0.16 0.02
Copper (mg) 0.077 0.029
Manganese (mg) 0.19 0.24
Zinc (mg) 0.21 0.44
aND: Not detected
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glucose, decreased blood cholesterol and triglyceride, or
decreased insulin requirements in both diabetic patients
and diabetic animals [41, 42]. In fact, the similarity of the
effects of both tomato and broccoli extracts to the ef-
fect of Chromax® on insulin and glucose levels in HFD
rats suggest that their effects may be acting through
the same mechanism. Although the exact mechanism
through which chromium supplements act to increase
insulin sensitivity is still unclear, it has been suggested
that it may act through the stimulation of tyrosine
kinase activity in insulin sensitive cells as well as anti-
inflammatory effects [41, 43–46].
We propose that lycopene of tomato extract reduces
oxidative stress due to inflammation associated with
obesity and consequently reduces resistin and other
associated adipocyte production. This in turn corrects
glucose and insulin levels in obesity and restores glucose
homeostasis. Also chromium in both tomato and broc-
coli extracts may stimulate tyrosine kinase activity in
glucose sensitive cells in addition to its potential anti-
inflammatory effects that may enhance glucose uptake
and maintain glucose homeostasis. This theory may
explain why tomato extract was more effective in
reducing blood glucose and insulin levels due to the
synergistic effects of lycopene and chromium in tomato
extract (Fig. 4).
In addition to the above-mentioned positive effects
of tomato and broccoli extracts, these vegetables
grown in Egypt also have high nutritional values
(please review Table 5). This strongly supports their
use as functional foods.
Conclusions
In conclusion, our results shows that tomato and broc-
coli extract one month treatment reduces serum resistin
and restores insulin sensitivity in HFD rats. Tomato ex-
tract was more effective than broccoli in reducing blood
glucose levels, however, further studies are required to
assess the potential use of these extract as a treatment
for type II diabetes in human and to determine its ef-
fective doses, as well as its active ingredients. Our study
also recommends the use of both tomato and broccoli
as a functional food with both nutritional and thera-
peutic values.
Additional file
Additional file 1: Individual data for serum resistin, leptin, and
adiponectin. (DOCX 18 kb)
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Fig. 3 Serum level of adiponectin (pg/ml) in the experimental groups.
Tomato and broccoli extracts increased serum levels of adiponectin in
the HFD rats at the end of 1 month treatment; C = control; HFD = high
fat diet; SD = stop diet; T 200 = tomato extract 200 mg/kg; T 400 =
tomato 400 mg/kg; B 200 = broccoli 200 mg/kg; B 400 = broccoli
400 mg/kg; CX = Chromax. Results were expressed as mean ± SEM and
analyzed using one-way ANOVA followed by Bonferroni’s post hoc test.
* = Significant from control at P < 0.0001, # = Significant from HFD at
P < 0.0001, $ = Significant from SD at P < 0.0001, @ = Significant from T
400 at P < 0.001
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